Microbial Models of Mammalian Metabolism: Production of Novel α-diketone Metabolites of Warfarin and Phenprocoumon Using Aspergillus Niger

References

• Benn R., Gunther H. Modern pulse methods in high resolution n.m.r. spectroscopy. Angewandte Chemie (International Edition in English) 1983; 22: 350–380
   Google Scholar
• Bruch M. D. Two‐dimensional n.m.r. spectroscopy of liquid, Chapter 3. NMR Spectroscopy Techniques, C. Dybowski, R. L. Lichter. Practical Spectroscopy Series, Marcel Dekker, , NY 1987; Vol. 5
   Google Scholar
• Clark A. M., McChesney J. D., Hufford C. D. Microbial models of mammalian drug metabolism. Medical Research Reviews 1985; 5: 231–253
   PubMed Web of Science ®Google Scholar
• Dagani R. In vitro methods may offer alternatives to animal testing. Chemistry and Engineering News Nov. 12, 1984; 25–28
   Web of Science ®Google Scholar
• Davis P. J. Microbial transformations: models of mammalian metabolism and catalysts in synthetic medicinal chemistry. Antibiotics and Microbial Transformations, S. B. Lamba. CRC Press, Boca Raton, Fla. 1987; 47–70
   Google Scholar
• Davis P. J. Microbial models of mammalian drug metabolism. Developments in Industrial Microbiology 1988; 29: 197–219
   Google Scholar
• Davis P. J., Rizzo J. D. Stereoselective reduction of warfarin by selected bacterial cultures. Applied Environmental Microbiology 1982; 43: 884–890
   PubMed Web of Science ®Google Scholar
• Fasco M. J., Vatsis K. P., Kaminsky L. S., Coon M. J. Regioselective and stereoselective hydroxylation of R and S‐warfarin by different forms of purified cytochrome P‐450 from rabbit liver. Journal of Biological Chemistry 1978; 21: 7813–7820
   Google Scholar
• Fasco M. J., Piper L. J., Kaminsky L. S. Biochemical application of a quantitative high‐pressure liquid chromatographic assay of warfarin and its metabolites. Journal of Chromatography 1977; 131: 365–373
   PubMed Web of Science ®Google Scholar
• Fasco M. J., Piper L. J., Kaminsky L. S. Cumene hydroperoxide‐supported microsomal hydroxylations of warfarin: a probe of cytochrome P‐450 multiplicity and specificity. Biochemical Pharmacology 1979; 28: 97–103
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes P‐450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes from rats treated with phenobarbital or β‐naphthoflavone. Biochemistry 1982; 21: 6019–6030
   PubMed Web of Science ®Google Scholar
• Hewick D. S., McEwen J. Plasma half‐lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. Journal of Pharmacy and Pharmacology 1973; 25: 458–465
   PubMed Web of Science ®Google Scholar
• Jacques L. B. Anticoagulant Therapy. Charles C. Thomas, Pub., Springfield, IL 1965; 92
   Google Scholar
• Kaminsky L. S., Dunbar D. A., Wang P. P., Beaune P., Larrey D., Guengerich F. P., Schnellmann R. G., Sipes I. G. Human hepatic cytochrome P‐450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metabolism and Disposition 1984; 12: 470–477
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Fasco M. J., Guengerich F. P. Comparison of different forms of liver, kidney, and lung microsomal cytochrome P‐450 by immunological inhibition of regio‐ and stereoselective metabolism of warfarin. Journal of Biological Chemistry 1979; 254: 9657–9662
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Fasco M. J., Guengerich F. P. Comparison of different forms of purified cytochrome P‐450 from rat liver by immunological inhibition of regio‐ and stereoselective metabolism of warfarin. Journal of Biological Chemistry 1980; 255: 85–91
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Guengerich F. P., Dannan G. A., Aust S. D. Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component‐purified cytochrome P‐450 isozymes. Archives of Biochemistry and Biophysics 1983; 255: 398–404
   Google Scholar
• Kaminsky L. S., Piper L. J., McMartin D. N., Fasco M. J. Induction of hepatic microsomal cytochrome P‐450 by mirex and kepone. Toxicology and Applied Pharmacology 1978; 43: 327–338
   PubMed Web of Science ®Google Scholar
• Kieslich K. Microbial Transformations of Non‐steriodal Cyclic Compounds. Georg Thieme, Stuttgart 1975
   Google Scholar
• Moreland T. A., Hewick D. S. Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate. Biochemical Pharmacology 1975; 24: 1953–1957
   PubMed Web of Science ®Google Scholar
• O'Riley R. A. Interactions of several coumarin compounds with human and canine plasma albumins. Molecular Pharmacology 1971; 7: 209–218
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Nelson S. D., Porter W. R., Trager W. F., Fasco M. J., Baker F. D., Fenton J. W. Warfarin: Stereochemical aspects of its metabolism by rat liver microsomes. Biochemical Pharmacology 1976; 25: 2153–2162
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Porter W. R., Trager W. F., Fasco M. J., Fenton J. W. Stereochemical biotransformation of warfarin as a probe of the homogeneity and mechanism of microsomal hydroxylases. Biochemical Pharmacology 1977; 26: 109–114
   PubMed Web of Science ®Google Scholar
• Porter W. R., Wheeler C., Trager W. F. Changes in the metabolic profiles of R‐ and S‐ warfarin and R‐ and S‐phenprocoumon as a probe to categorize the effect of inducing agents on microsomal hydroxylases. Biochemical Pharmacology 1981; 30: 3099–3104
   PubMed Web of Science ®Google Scholar
• Reighard J. B., Knapp J. E. Microbial models of mammalian metabolism. Pharmacy International 1986; 7: 92–94
   Google Scholar
• Rettie A. E., Heimark L., Mayer R. T., Burke M. D., Trager W. F., Juchau M. R. Stereoselective and regioselective hydroxylation of warfarin and selective O‐dealkylation of phenoxazone ethers in human placenta. Biochemistry and Biophysics Research Communications 1985; 126: 1013–1021
   PubMed Web of Science ®Google Scholar
• Rizzo J. D., Davis P. J. Microbial models of mammalian metabolism: Conversion of warfarin to 4′‐hydroxywarfarin using Cunninghamella bainieri (UI 3065). Journal of Pharmaceutical Sciences 1988, in press
   Web of Science ®Google Scholar
• Rosazza J. P. Antitumor antibiotic bioactivation, biotransformation, and derivatization by microbial systems. Recent Results in Cancer Research 1978; 63: 58–68
   PubMedGoogle Scholar
• Rosazza J. P., Smith R. V. Microbial models for drug metabolism. Advances in Applied Microbiology 1979; 25: 169–208
   PubMedGoogle Scholar
• Smith R. V., Davis J. P. Induction of xenobiotic monooxygenases. Advances in Biochemical Engineering 1980; 14: 61–100
   Google Scholar
• Smith R. V., Rosazza J. P. Microbial models for mammalian metabolism. Journal of Pharmaceutical Sciences 1975; 64: 1737–1759
   PubMed Web of Science ®Google Scholar
• Smith R. V., Rosazza J. P. Microbial transformations as a means of preparing mammalian drug metabolites. Microbial Transformations of Bioactive Compounds, J. P. Rosazza. CRC Press, Boca Raton, Fla. 1982; Vol. 2: 1–42
   Google Scholar
• Smith R. V., Rosazza J. P. Microbial models of mammalian metabolism. Journal of Natural Products 1983; 46: 79–91
   PubMed Web of Science ®Google Scholar
• Smith R. V., Acosta D., Rosazza J. P. Microbial and cellular models for mammalian metabolism. Advances in Biochemical Engineering 1977; 5: 69–100
   Google Scholar
• Thonnart N., Vanhaelen M., Vanhaelen‐Fastre R. In vitro metabolism of a new 4‐ hydroxycoumarin anticoagulant. Structure of an unusual metabolite. Journal of Medicinal Chemistry 1977; 20: 604–606
   PubMed Web of Science ®Google Scholar
• Thonnart N., Vanhaelen M., Vanhaelen‐Fastre R. In vitro metabolism of clocoumarol, a new 4‐hydroxycoumarin anticoagulant: identification of two additional metabolites. Drug Metabolism and Disposition 1979; 7: 449–450
   PubMed Web of Science ®Google Scholar
• Trager W. F., Lewis R. J., Garland W. A. Mass spectral analysis of human metabolites of warfarin. Journal of Medicinal Chemistry 1970; 13: 1196–1204
   PubMed Web of Science ®Google Scholar
• Valente E. J., Lingafelter E. C., Porter W. R., Trager W. F. Structure of warfarin in solution. Journal of Medicinal Chemistry 1977; 20: 1489–1493
   PubMed Web of Science ®Google Scholar
• Wang P. P., Beaune P., Kaminsky L. S., Dannan G. A., Kadlubar F. F., Larrey D., Guengerich F. P. Purification of six cytochrome P‐450 isozymes from human liver microsomes. Biochemistry 1983; 22: 5375–5383
   PubMed Web of Science ®Google Scholar
• West B. D., Link K. P. The resolution and absolute configuration of ‐marcumar' (phenprocoumon). Journal of Heterocyclic Chemistry 1965; 2: 93–94
   Web of Science ®Google Scholar